Clinical Trial: TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT03916913) titled 'TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC' on April 13.

Brief Summary: In this phase II trial with single arm, we aim to investigate the clinical efficacy and toxicity profile of local radiotherapy on all disease sites for EGFR-mutant oligo-metastatic NSCLC (no more than 3 metastatic lesions) who did not experience disease progression after at least 3 months of TKI therapy.

Study Type: Interventional

Condition: Non-Small Cell Lung Cancer Metastatic

Intervention: Radiation: Local radiation therapy

Local radiotherapy on all sites of disease including primary and metastatic lesions

Recruitment Status: R...